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Clear cell meningiomas are a rare variant of meningioma that generally occur in the cerebellopontine angle and the spine.1 
Despite its bland histological appearance, this tumour 
is classified as a World Health Organisation (WHO) 
grade II neoplasm due to its aggressive nature and 
high propensity for recurrence and spinal seeding.2 
Although they usually occur in a much younger 
age group than most other meningiomas, clear cell 
meningiomas are still rare in infancy.3 This case 
describes a rare case of meningioma with unusual 
characteristics, which included a very early age 
of occurrence and the supratentorial location of 
the tumour.
Case Report
An 8-month-old male infant was referred to the 
Lagos University Teaching Hospital, Lagos, Nigeria, 
in 2015 with persistent vomiting, poor feeding 
and failure to thrive over a four month period. The 
vomiting was postprandial and the contents contained 
recently ingested food. There was no history of loss of 
consciousness, seizures or fever. The patient’s father 
reported that the child could not see using his right 
eye. The pregnancy, delivery and perinatal history 
had been unremarkable and there was no history of 
maternal exposure to radiation.
On examination, the child was fully conscious and 
undernourished, weighing 6 kg (60% of his expected 
weight). He was not pale, cyanosed or dehydrated. His 
pupils measured 3 mm and were reactive bilaterally; 
however, a fundoscopic examination revealed bilateral 
optic atrophy. Generalised hypertonia and hyper-
reflexia were also noted. A computed tomography 
scan of the brain revealed a huge largely isodense 
suprasellar mass with a hypodense core. The mass 
measured 6 x 5 x 4 cm, enhanced non-uniformly with 
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ورم السحايا ذي اخلاليا الصافية يف منطقة فوق السرج لطفل رضيع
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abstract: Clear cell meningiomas are an uncommon subtype of meningioma rarely seen in infancy. We report 
a case of clear cell meningioma in an 8-month-old male infant. He presented at the Lagos University Teaching 
Hospital, Lagos, Nigeria, in 2015 with persistent vomiting, poor feeding and failure to thrive over a four month 
period. Generalised hypertonia and hyperreflexia were noted on examination. Computed tomography of the brain 
revealed a huge largely isodense suprasellar mass with a hypodense core. The tumour, which measured 6 x 5 x 4 cm, 
enhanced non-uniformly with contrast injection and extended to occlude the third ventricle. The patient underwent 
a bifrontal craniotomy with subtotal tumour excision. Six hours postoperatively, he went into cardiac arrest and 
could not be resuscitated. A histological diagnosis of clear cell meningioma was made as the tumour cells were 
immunoreactive to epithelial membrane antigen, S100 protein and vimentin. This case of clear cell meningioma was 
unusual due to its early occurrence and supratentorial location.
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امللخ�ص: تعترب اأورام ال�صحايا ذات اخلاليا ال�صافية من االأورام الغري �صائعة يف االأطفال الر�صع. هذا تقرير حالة لطفل ر�صيع ذكر يبلغ 8 
�صهور من العمر. وقد مت تنوميه يف م�صت�صفي الجو�ض اجلامعي التعليمي يف العام 2015م ب�صبب قئ متوا�صل و عدم قابلية للر�صاعة  وعدم 
النمو على مدى اأربعة �صهور متتالية. وعند الفح�ض ال�رضيري للطفل وجد اأنه يعاين من نق�ض عام يف توتر الع�صالت مع وجود فرط يف 
املنعك�صات الع�صبية. واثبتت االأ�صعة املقطعية على املخ بالكمبيوتر وجود ورم �صخم مت�صاوي الكثافة فوق ال�رضج ومنخف�ض الكثافة يف 
6 �صم واأظهر عدم جتان�ض با�صتخدام �صبغة التباين واأمتد الورم ايل البطني الثالث، وقد مت اإجراء عملية  x 5 x 4 الو�صط. وقد بلغ حجم الورم
ا�صتئ�صال غري كامل للورم عن طريق حج القحف )�صق اجلمجمة( من الناحيتني االأماميتني، وبعد العملية ب�صتة �صاعات توقفت ع�صلة القلب 
للطفل وف�صلت حماوالت اإنعا�صه، وبالفح�ض الن�صيجي مت ت�صخي�ض ورم خاليا ال�صحايا الوا�صح واأظهرت خاليا الورم تفاعاًل مناعيًا مع 
بروتني الغ�صاء الظاهري S100 والفاميننت، وهذه احلالة غري عادية نتيجًة حلدوثها يف عمٍر مبكٍر واأي�صًا لتواجدها فوق اخليمة املخية.
كلمات مفتاحية: ورم خاليا ال�صحايا الوا�صح؛ ورم خمي؛ اأورام اجلهاز الع�صبي املركزي؛ طفل ر�صيع؛ تقرير حالة؛ نيجرييا.
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contrast injection and extended superiorly to efface the 
third ventricle [Figure 1]. A bifrontal craniotomy was 
performed. Intraoperatively, the tumour contained 
areas which felt hard and gritty to the touch, while 
other areas were soft and jelly-like in consistency. It 
was adherent to the optic nerves bilaterally and the 
optic chiasm and was successfully separated from the 
left optic nerve and the optic chiasm during surgery. 
However, attempts to separate the tumour from the 
right optic nerve proved unsuccessful, resulting in 
subtotal excision of the tumour. The patient was 
transfused with 480 mL of blood intraoperatively. He 
was transferred postoperatively to the Intensive Care 
Unit where he subsequently developed hyperthermia 
(temperature: >40 °C) and tachycardia (pulse rate 
range: 180–240 beats per minute). Six hours following 
the operation, the patient went into cardiac arrest and 
unfortunately could not be resuscitated.
Histopathological assessment of the tumour 
revealed proliferating meningothelial cells, many of 
which had clear cytoplasm within a densely fibrotic 
stroma. The cells formed a vague whorled pattern in 
some foci and had a bland cytological appearance. 
Mitoses were scanty and areas of cystic degeneration 
and vascular congestion were seen [Figure 2A]. The 
tumour cells showed immunoreactivity to epithelial 
membrane antigen (EMA), vimentin and S100 protein 
[Figures 2B–D]. A diagnosis of clear cell meningioma 
was made.
Discussion
Like other meningiomas, clear cell meningiomas are 
tumours of meningothelial cells, which are normally 
scattered in the arachnoid membranes throughout 
the neuraxis but have their highest concentration at 
the tips of the arachnoid granulations, where they are 
called arachnoid cap cells.4 In clear cell meningiomas, 
the meningothelial cells accumulate glycogen which 
results in a clear appearance.2 Clear cell meningiomas 
are rare tumours that account for 0.2–0.8% of all 
meningiomas and thus few cases have been reported 
in the literature.5 Clear cell meningiomas, as with other 
meningiomas, show a slight female predominance.1 
The current case was unusual in view of the very 
early age of tumour occurrence and the supratentorial 
location of the tumour. Clear cell meningiomas 
are more commonly seen in younger children and 
adolescents.3,5,6 In a study of 14 patients ranging from 
9 to 82 years old, the mean age of occurrence was 29 
years.6 In another study of nine cases diagnosed over 
an eight year period, the median age of occurrence 
was 26 years.5 These are much lower than the usual 
ages of occurrence of other types of meningioma, 
which have been reported variously to be during 
the fourth, fifth, sixth and ninth decades in Lagos, 
South Africa, Egypt and the USA, respectively.7–10 
The patient in the current case presented at eight 
months of age, which is an unusually young age of 
occurrence for clear cell meningiomas. There are only 
a few reports of this tumour occurring in infancy; 
among these, most tumours were located in the 
intraspinal compartment.11,12 In general, most clear 
 
Figure 1: Brain computed tomography scan showing an 
isodense suparasellar mass (arrow) in an 8-month-old 
infant with a suprasellar clear cell meningioma.
 
Figure 2A–D: Photomicrographs of (A) a haematoxylin 
and eosin stain at x1,000 magnification showing 
meningothelial cells with clear cytoplasm within a 
fibrotic stroma (arrow) and (B) epithelial membrane 
antigen stain at x1,000 magnification, (C) vimentin stain 
at x1,000 magnification and (D) S100 stain at x1,000 
magnification showing immunoreactivity. 
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Conclusion
This report described an 8-month-old infant with 
clear cell meningioma diagnosed postoperatively by 
histopathological assessment. Both the early present-
ation at infancy and supratentorial location of the 
tumour were unusual features; most cases occur in 
younger children or adolescents and the tumours 
usually have an infratentorial location. The optimal 
treatment for this rare subtype of meningioma is total 
surgical resection, with radiotherapy, chemotherapy 
and receptor-targeted therapy being reserved for 
recurrent cases.
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cell meningiomas have an infratentorial location.1 
However, in the present case, the tumour was located 
in the suprasellar region; this location accounted for 
only 4.3% of meningiomas reported in a previous 
study conducted at the Lagos University Teaching 
Hospital.7 Other rare tumour locations that have 
been reported include the foramen magnum and the 
fourth ventricle.6,13
The histological differential diagnosis of primary 
central nervous system tumours with a clear cell 
morphology includes clear cell meningiomas, neuro-
cytomas, oligodendrogliomas, ependymomas and 
haemangioblastomas.14 Clear cell meningiomas are 
characterised histologically by the presence of 
polygonal cells with clear glycogen-rich cytoplasm, 
often in no particular pattern, within a densely fibrotic 
stroma.2 Whorl formation is vague and psammoma 
bodies are not usually seen.2 The tumour cells are 
usually immunoreactive to EMA, S100 protein and 
vimentin—as was the case for the current patient—
and are usually negative for synaptophysin, glial 
fibrillary acidic protein, cytokeratins and desmin.1 In 
ultrastructural studies, the clear cell meningioma cells 
should have intercellular junctions, interdigitating 
processes and intermediate vimentin filaments.14 
Unlike other WHO grade II meningiomas, which tend 
to have a mitotic count greater than four per 10 high-
power fields, clear cell meningiomas often have low 
mitotic activity; moreover, mitosis has been shown to 
be of no value in predicting the aggressiveness of the 
neoplasm.1,2,6 Jain et al. found that the MIB-1 labelling 
index of clear cell meningiomas ranged from 2–12%.5 
Deb et al. reported a MIB-1 labelling index of <1% in a 
case of recurrent clear cell meningioma.1
Proliferating cell nuclear antigen proliferative 
indices, percentage S-phase determination and DNA 
ploidy have been linked with aggressiveness in clear cell 
meningiomas.6,13 Closer follow-up is therefore required 
for these cases. Furthermore, germline SMARCE 1 
(SWItch/sucrose non-fermentable-related matrix-
associated actin-dependent regulator of chromatin 
subfamily E member 1) mutations have been linked 
with spinal and cranial clear cell meningiomas.15,16 
Smith et al. identified SMARCE 1 mutations and 
loss of SMARCE 1 proteins in patients and paraffin-
embedded tissue blocks of spinal and cranial clear 
cell meningioma cases.15 The treatment of choice 
for clear cell meningiomas is total surgical resection, 
with radiotherapy and chemotherapy being reserved 
for recurrent cases.1 Juratli et al. observed increasing 
overexpression of epidermal growth factor, platelet-
derived growth factor and vascular endothelial growth 
factor receptors with each recurrent tumour; receptor-
targeted therapy was therefore recommended for 
such tumours.17
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